Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Tissue Engineering and Regenerative Medicine is Scopus-indexed (Q1, CiteScore 7.8), WoS SCIE. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 1932-6254Verify ISSN ↗1932-7005Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: About US$2,490 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 58 / 466 | 87th | Q1 |
| Biomedical Engineering | 87 / 342 | 74th | Q2 |
| Biomaterials | 49 / 146 | 66th | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q1, CiteScore 7.8.
Journal of Tissue Engineering and Regenerative Medicine is Q1 in Medicine (miscellaneous) (rank 58 of 466), Q2 in Biomedical Engineering (rank 87 of 342) and Q2 in Biomaterials (rank 49 of 146), by CiteScore 2025.
Journal of Tissue Engineering and Regenerative Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.8, which places it in quartile Q1 at the 87th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.620, quartile Q2, with an H-index of 101.
The publisher lists an article processing charge of about US$2,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Tissue Engineering and Regenerative Medicine is published by John Wiley and Sons Inc. Its print ISSN is 1932-6254 and its online ISSN is 1932-7005.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Tissue Engineering and Regenerative Medicine has an h-index of 111 and a 2-year mean of 2.45 citations per paper (OpenAlex). Its Scopus CiteScore is 7.8, quartile Q1. On 2-year citations it ranks #130 of 451 Scopus journals in Medicine (miscellaneous).
Journal of Tissue Engineering and Regenerative Medicine published 22 papers in 2025; its busiest recent year was 2017 with 283. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2022–2026), authors are most often from United States (27.8%), China (22.5%) and Germany (8.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 9 retracted papers are recorded (3.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.